Cargando…

Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap

Detalles Bibliográficos
Autores principales: Erfani, Parsa, Bates, Michael, Garcia-Gonzalez, Pat, Milner, Dan A., Rebbeck, Timothy R., Ruhangaza, Deogratias, Shulman, Lawrence N., Fadelu, Temidayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812500/
https://www.ncbi.nlm.nih.gov/pubmed/36252158
http://dx.doi.org/10.1200/GO.22.00182
_version_ 1784863740925050880
author Erfani, Parsa
Bates, Michael
Garcia-Gonzalez, Pat
Milner, Dan A.
Rebbeck, Timothy R.
Ruhangaza, Deogratias
Shulman, Lawrence N.
Fadelu, Temidayo
author_facet Erfani, Parsa
Bates, Michael
Garcia-Gonzalez, Pat
Milner, Dan A.
Rebbeck, Timothy R.
Ruhangaza, Deogratias
Shulman, Lawrence N.
Fadelu, Temidayo
author_sort Erfani, Parsa
collection PubMed
description
format Online
Article
Text
id pubmed-9812500
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-98125002023-01-05 Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap Erfani, Parsa Bates, Michael Garcia-Gonzalez, Pat Milner, Dan A. Rebbeck, Timothy R. Ruhangaza, Deogratias Shulman, Lawrence N. Fadelu, Temidayo JCO Glob Oncol COMMENTARIES Wolters Kluwer Health 2022-10-17 /pmc/articles/PMC9812500/ /pubmed/36252158 http://dx.doi.org/10.1200/GO.22.00182 Text en © 2022 by American Society of Clinical Oncology https://creativecommons.org/licenses/by-nc-nd/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle COMMENTARIES
Erfani, Parsa
Bates, Michael
Garcia-Gonzalez, Pat
Milner, Dan A.
Rebbeck, Timothy R.
Ruhangaza, Deogratias
Shulman, Lawrence N.
Fadelu, Temidayo
Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
title Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
title_full Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
title_fullStr Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
title_full_unstemmed Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
title_short Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap
title_sort leveraging molecular diagnostic technologies to close the global cancer pathology gap
topic COMMENTARIES
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812500/
https://www.ncbi.nlm.nih.gov/pubmed/36252158
http://dx.doi.org/10.1200/GO.22.00182
work_keys_str_mv AT erfaniparsa leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap
AT batesmichael leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap
AT garciagonzalezpat leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap
AT milnerdana leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap
AT rebbecktimothyr leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap
AT ruhangazadeogratias leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap
AT shulmanlawrencen leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap
AT fadelutemidayo leveragingmoleculardiagnostictechnologiestoclosetheglobalcancerpathologygap